Dattola, Annunziata, et al. “Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-Week Multicentric Real-Life Experience in Lazio, Italy”. Dermatology Practical & Conceptual, vol. 15, no. 2, Apr. 2025, p. 4976 , https://doi.org/10.5826/dpc.1502a4976.